18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age

A 0 1 16 17 O
baseline 2 10 18 26 O
creatinine 11 21 27 37 B-clinical_variable
reported 22 30 38 46 O
as 31 33 47 49 O
> 34 35 50 51 O
2.0 36 39 52 55 B-lower_bound
mg 40 42 56 58 I-lower_bound
/ 42 43 58 59 I-lower_bound
dL 43 45 59 61 I-lower_bound

Evidence 0 8 62 70 O
of 9 11 71 73 O
distant 12 19 74 81 B-cancer
metastases 20 30 82 92 I-cancer
of 31 33 93 95 O
stage 34 39 96 101 B-lower_bound
IV 40 42 102 104 I-lower_bound

Have 0 4 105 109 O
a 5 6 110 111 O
history 7 14 112 119 O
of 15 17 120 122 O
epilepsy 18 26 123 131 B-chronic_disease
or 27 29 132 134 O
cardiac 30 37 135 142 B-chronic_disease
arrhythmia 38 48 143 153 I-chronic_disease
( 49 50 154 155 O
atrial 50 56 155 161 B-chronic_disease
or 57 59 162 164 O
ventricular 60 71 165 176 B-chronic_disease
fibrillation 72 84 177 189 I-chronic_disease
) 84 85 189 190 O

Have 0 4 191 195 O
a 5 6 196 197 O
recent 7 13 198 204 O
history 14 21 205 212 O
of 22 24 213 215 O
myocardial 25 35 216 226 B-chronic_disease
infarction 36 46 227 237 I-chronic_disease
( 47 48 238 239 O
within 48 54 239 245 O
the 55 58 246 249 O
past 59 63 250 254 B-upper_bound
2 64 65 255 256 I-upper_bound
months 66 72 257 263 I-upper_bound
) 72 73 263 264 O

Have 0 4 265 269 O
any 5 8 270 273 O
reported 9 17 274 282 O
baseline 18 26 283 291 O
lab 27 30 292 295 O
values 31 37 296 302 O
with 38 42 303 307 O
a 43 44 308 309 O
grade 45 50 310 315 B-lower_bound
3 51 52 316 317 I-lower_bound
or 53 55 318 320 O
4 56 57 321 322 B-upper_bound
toxicity 58 66 323 331 O
as 67 69 332 334 O
defined 70 77 335 342 O
by 78 80 343 345 O
the 81 84 346 349 O
CTCAE 85 90 350 355 B-clinical_variable
Version 91 98 356 363 I-clinical_variable
3.0 99 102 364 367 I-clinical_variable

Have 0 4 368 372 O
implanted 5 14 373 382 O
cardiac 15 22 383 390 B-treatment
pacemakers 23 33 391 401 I-treatment
or 34 36 402 404 O
defibrillators 37 51 405 419 B-treatment

Have 0 4 420 424 O
taken 5 10 425 430 O
an 11 13 431 433 O
investigational 14 29 434 449 B-treatment
agent 30 35 450 455 I-treatment
within 36 42 456 462 O
30 43 45 463 465 B-upper_bound
days 46 50 466 470 I-upper_bound
of 51 53 471 473 O
visit 54 59 474 479 O
1 60 61 480 481 O

Have 0 4 482 486 O
taken 5 10 487 492 O
any 11 14 493 496 O
chemotherapeutic 15 31 497 513 B-treatment
agent 32 37 514 519 I-treatment
within 38 44 520 526 O
5 45 46 527 528 B-upper_bound
weeks 47 52 529 534 I-upper_bound
of 53 55 535 537 O
treatment 56 65 538 547 B-treatment
with 66 70 548 552 I-treatment
the 71 74 553 556 I-treatment
NanoKnife 75 84 557 566 I-treatment
Irreversible 85 97 567 579 I-treatment
Electroporation 98 113 580 595 I-treatment
( 114 115 596 597 I-treatment
IRE 115 118 597 600 I-treatment
) 118 119 600 601 I-treatment
System 120 126 602 608 I-treatment

Inability 0 9 609 618 O
to 10 12 619 621 O
stop 13 17 622 626 O
antiplatelet 18 30 627 639 B-treatment
and 31 34 640 643 O
coumadin 35 43 644 652 B-treatment
therapy 44 51 653 660 I-treatment
for 52 55 661 664 O
7 56 57 665 666 B-upper_bound
days 58 62 667 671 I-upper_bound
prior 63 68 672 677 I-upper_bound
to 69 71 678 680 O
and 72 75 681 684 O
7 76 77 685 686 O
days 78 82 687 691 O
post 83 87 692 696 O
treatment 88 97 697 706 B-treatment
with 98 102 707 711 O
the 103 106 712 715 O
NanoKnife 107 116 716 725 B-treatment
System 117 123 726 732 I-treatment

Known 0 5 733 738 O
history 6 13 739 746 O
of 14 16 747 749 O
contrast 17 25 750 758 B-allergy_name
allergy 26 33 759 766 I-allergy_name
that 34 38 767 771 O
can 39 42 772 775 O
not 42 45 775 778 O
be 46 48 779 781 O
medically 49 58 782 791 O
managed 59 66 792 799 O

Known 0 5 800 805 O
hypersensitivity 6 22 806 822 O
to 23 25 823 825 O
the 26 29 826 829 O
metal 30 35 830 835 B-allergy_name
in 36 38 836 838 O
the 39 42 839 842 O
electrodes 43 53 843 853 O
( 54 55 854 855 O
stainless 55 64 855 864 B-allergy_name
steel 65 70 865 870 I-allergy_name
304L 71 75 871 875 I-allergy_name
) 75 76 875 876 O
that 77 81 877 881 O
can 82 85 882 885 O
not 85 88 885 888 O
be 89 91 889 891 O
medically 92 101 892 901 O
managed 102 109 902 909 O

Male 0 4 910 914 B-gender

Must 0 4 915 919 O
be 5 7 920 922 O
found 8 13 923 928 O
to 14 16 929 931 O
have 17 21 932 936 O
locally 22 29 937 944 O
advanced 30 38 945 953 O
unresectable 39 51 954 966 O
disease 52 59 967 974 O
following 60 69 975 984 O
standard 70 78 985 993 O
chemotherapy 79 91 994 1006 B-treatment
Â± 92 93 1007 1008 O
radiotherapy 94 106 1009 1021 B-treatment
as 107 109 1022 1024 O
demonstrated 110 122 1025 1037 O
with 123 127 1038 1042 O
either 128 134 1043 1049 O
CT 135 137 1050 1052 B-treatment
/ 137 138 1052 1053 O
MRI 138 141 1053 1056 B-treatment
imaging 142 149 1057 1064 I-treatment
and 150 153 1065 1068 O
surgical 154 162 1069 1077 B-treatment
evaluation 163 173 1078 1088 I-treatment
, 173 174 1088 1089 O
and 175 178 1090 1093 O
not 179 182 1094 1097 O
have 183 187 1098 1102 O
taken 188 193 1103 1108 O
any 194 197 1109 1112 O
chemotherapy 198 210 1113 1125 O
/ 210 211 1125 1126 O
radiotherapy 211 223 1126 1138 O
within 224 230 1139 1145 O
5 231 232 1146 1147 B-upper_bound
weeks 233 238 1148 1153 I-upper_bound
of 239 241 1154 1156 O
treatment 242 251 1157 1166 B-treatment
with 252 256 1167 1171 I-treatment
the 257 260 1172 1175 I-treatment
NanoKnife 261 270 1176 1185 I-treatment
IRE 271 274 1186 1189 I-treatment
System 275 281 1190 1196 I-treatment

Must 0 4 1197 1201 O
have 5 9 1202 1206 O
an 10 12 1207 1209 O
INR 13 16 1210 1213 B-clinical_variable
< 17 18 1214 1215 O
1.5 19 22 1216 1219 B-upper_bound

Receive 0 7 1220 1227 O
non 8 11 1228 1231 O
- 11 12 1231 1232 O
conventional 12 24 1232 1244 O
fractionation 25 38 1245 1258 O
schedules 39 48 1259 1268 O
, 48 49 1268 1269 O
such 50 54 1270 1274 O
as 55 57 1275 1277 O
stereotactic 58 70 1278 1290 B-treatment
radiation 71 80 1291 1300 I-treatment
( 81 82 1301 1302 O
5 82 83 1302 1303 B-lower_bound
fractions 84 93 1304 1313 I-lower_bound
or 94 96 1314 1316 O
less 97 101 1317 1321 O
) 101 102 1321 1322 O

Tumor 0 5 1323 1328 B-cancer
size 6 10 1329 1333 O
not 11 14 1334 1337 O
measurable 15 25 1338 1348 O

Unable 0 6 1349 1355 O
to 7 9 1356 1358 O
be 10 12 1359 1361 O
treated 13 20 1362 1369 O
with 21 25 1370 1374 O
a 26 27 1375 1376 O
muscle 28 34 1377 1383 B-treatment
blockade 35 43 1384 1392 I-treatment
agent 44 49 1393 1398 I-treatment

Women 0 5 1399 1404 B-gender
of 6 8 1405 1407 O
childbearing 9 21 1408 1420 O
potential 22 31 1421 1430 O
who 32 35 1431 1434 O
are 36 39 1435 1438 O
not 40 43 1439 1442 B-contraception_consent
utilizing 44 53 1443 1452 I-contraception_consent
an 54 56 1453 1455 I-contraception_consent
acceptable 57 67 1456 1466 I-contraception_consent
method 68 74 1467 1473 I-contraception_consent
of 75 77 1474 1476 I-contraception_consent
contraception 78 91 1477 1490 I-contraception_consent

Women 0 5 1491 1496 B-gender
who 6 9 1497 1500 O
are 10 13 1501 1504 O
pregnant 14 22 1505 1513 B-pregnancy

atracurium 0 10 1514 1524 B-treatment

cisatracurium 0 13 1525 1538 B-treatment

female 0 6 1539 1545 B-gender

pancuronium 0 11 1546 1557 B-treatment
bromide 12 19 1558 1565 I-treatment

received 0 8 1566 1574 O
higher 9 15 1575 1581 O
than 16 20 1582 1586 O
54 21 23 1587 1589 B-lower_bound
Gray 24 28 1590 1594 I-lower_bound
( 29 30 1595 1596 I-lower_bound
Gy 30 32 1596 1598 I-lower_bound
) 32 33 1598 1599 I-lower_bound
delivered 34 43 1600 1609 O
conventionally 44 58 1610 1624 O

